Open Access

[Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression

  • Authors:
    • Angeles Hernandez‑Cueto
    • Daniel Hernandez‑Cueto
    • Gabriela Antonio‑Andres
    • Marisela Mendoza‑Marin
    • Carlos Jimenez‑Gutierrez
    • Ana Lilia Sandoval‑Mejia
    • Rosario Mora‑Campos
    • Cesar Gonzalez‑Bonilla
    • Mario I. Vega
    • Benjamin Bonavida
    • Sara Huerta‑Yepez
  • View Affiliations

  • Published online on: August 11, 2017     https://doi.org/10.3892/mmr.2017.7234
  • Pages: 5738-5738
  • Copyright: © Hernandez‑Cueto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

During the preparation of the figures in the above article, the authors inadvertently duplicated in Fig. 1B, a and b (high and low magnification images) the images that had already appeared as Figs. 5A, a and c (high and low magnification images), respectively, of the following paper: Huerta-Yepez S, Baritaki S, Baay-Guzman G, Hernandez-Luna MA, Hernandez-Cueto A, Vega MI and Bonavida B: Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. Nitric Oxide 29: 17-24, 2013. The revised version of Fig. 1 containing the corrected data for Fig. 1B, a and b (high and low magnification images; the YY1 data) is shown opposite protein expression. All those authors whom the corresponding author was able to contact have agreed to this Corrigendum. The authors regret this error, and apologize for any confusion that it may have caused. [the original article was published in the Molecular Medicine Reports 10: 2279-2286, 2014; DOI: 10.3892/mmr.2014.2504 ]

Related Articles

Journal Cover

October-2017
Volume 16 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hernandez‑Cueto A, Hernandez‑Cueto D, Antonio‑Andres G, Mendoza‑Marin M, Jimenez‑Gutierrez C, Sandoval‑Mejia AL, Mora‑Campos R, Gonzalez‑Bonilla C, Vega MI, Bonavida B, Bonavida B, et al: [Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression. Mol Med Rep 16: 5738-5738, 2017
APA
Hernandez‑Cueto, A., Hernandez‑Cueto, D., Antonio‑Andres, G., Mendoza‑Marin, M., Jimenez‑Gutierrez, C., Sandoval‑Mejia, A.L. ... Huerta‑Yepez, S. (2017). [Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression. Molecular Medicine Reports, 16, 5738-5738. https://doi.org/10.3892/mmr.2017.7234
MLA
Hernandez‑Cueto, A., Hernandez‑Cueto, D., Antonio‑Andres, G., Mendoza‑Marin, M., Jimenez‑Gutierrez, C., Sandoval‑Mejia, A. L., Mora‑Campos, R., Gonzalez‑Bonilla, C., Vega, M. I., Bonavida, B., Huerta‑Yepez, S."[Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression". Molecular Medicine Reports 16.4 (2017): 5738-5738.
Chicago
Hernandez‑Cueto, A., Hernandez‑Cueto, D., Antonio‑Andres, G., Mendoza‑Marin, M., Jimenez‑Gutierrez, C., Sandoval‑Mejia, A. L., Mora‑Campos, R., Gonzalez‑Bonilla, C., Vega, M. I., Bonavida, B., Huerta‑Yepez, S."[Corrigendum] Death receptor 5 expression is inversely correlated with prostate cancer progression". Molecular Medicine Reports 16, no. 4 (2017): 5738-5738. https://doi.org/10.3892/mmr.2017.7234